News | October 31, 2023
Sun Pharma to co-market Zydus’s CKD treatment drug ‘Desidustat’ in India
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Prateek has more than 23 years of rich experience in Human Resource
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
Dr. Singh proposes upskilling medicos with AI, Quantum and other newer technologies to meet the changing requirements of patient care
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Subscribe To Our Newsletter & Stay Updated
